Title
Category
Credits
Event date
Cost
  • AMA PRA Category 1 Credit™
  • Attendance
11/11/2021
$1.00
Needs StatementAs many as 20 percent of children and adults have significant mental and behavioral health concerns at any given time. Exposure to a disaster like Hurricane Harvey and the trauma that comes with it often exacerbates pre-existing issues and/or brings new issues to the surface, with post-traumatic stress often presenting as “other” mental illnesses, including anxiety, ADHD, depression, school conduct issues or even physical illness. The result is a large and complex problem that must be addressed.
  • AMA PRA Category 1 Credit™
  • Attendance
11/11/2021
$0.00
Needs StatementThis activity is to provide the most up-to-date AUA Guidelines and recommendations for PSA Screening, evidence-based benefits of PSA screening, and sharing the changes of USPSTF Recommendations for prostate cancer screening for physicians.
  • AMA PRA Category 1 Credit™
  • Attendance
11/18/2021
$1.00
OverviewIn September of 2017, the National Institute of Mental Health’s  Division of Intramural Research Programs (IRP) convened a workshop to develop and promote Electrophysiologic Sleep Phenotyping (ESP) as a mainstay of the clinical assessment of children at risk for neurodevelopmental disorders (see: https://www.nimh.nih.gov/news/events/2017/sleep-and-neurodevelopment-workshop-electrophysiologic-sleep-phenotyping-esp.shtml).
  • AMA PRA Category 1 Credit™
  • Attendance
  • Ethics
12/01/2021
$0.00
OverviewFaculty educators most commonly fall back on their own learning to guide development of curriculum, formal or informal. Traditional, lecture-based teaching does not engage the important processes required for long-term learning and application of learning. This activity is to improve knowledge of the principles of active learning and how to facilitate its use in different learning environments.
  • AMA PRA Category 1 Credit™
  • ANCC
  • Attendance
  • Ethics
02/05/2022
$1.00
Virtual ConferenceFebruary 5, 2022Needs StatementCardiovascular disease is the leading global cause of mortality and morbidity. We are creating new interconnecting paradigms for the practice of cardiovascular disease prevention. This forum is filling the gap of applying the new scientific advances in technology and basic medical science to the clinical practice of cardiovascular disease prevention.